Skip to main content
Clinical Trials/ACTRN12617001201369
ACTRN12617001201369Completed未知

Prostate Artery Embolisation Assessment of Safety and Efficacy with preliminary and follow-up urodynamic studies in men with symptomatic benign prostate hyperplasia (P-EASY PLUS)

Wesley Medical Imaging0 sites105 target enrollmentStarted: August 16, 2017Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
105

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment

Eligibility Criteria

Ages
50 Years to 80 Years (—)
Sex
Male

Inclusion Criteria

  • BPH with prostate volume > 40cc
  • Moderate-severe lower urinary tract symptoms (IPSS >8)
  • Peak urinary flow <12ml/sec
  • Obstructive urodynamics
  • Medically refractory lower urinary tract symptoms >6 months
  • Unsuitable for, or unwilling to undergo, surgical prostate resection, in consultation with a urological surgeon

Exclusion Criteria

  • Prostate malignancy
  • Neurogenic bladder
  • Renal failure eGFR <35ml/min
  • Severe contrast allergy
  • Severe peripheral vascular disease
  • Urethral or bladder pathology

Investigators

Sponsor
Wesley Medical Imaging

Similar Trials

Prostate Artery Embolisation Assessment of... | Clinical Trial